Tue, Dec 23, 2014, 12:26 AM EST - U.S. Markets open in 9 hrs 4 mins

Recent

% | $
Quotes you view appear here for quick access.

Impax Laboratories Inc. Message Board

  • cobbob46 cobbob46 Oct 28, 2012 10:21 PM Flag

    Mylan is seeking at 3-4 billion purchase in generic space and also seeking Proprietary addions= IPXL

    This move would make more sense than anything. May already be in the Works and talks with JPM due to the pathetic Golman rating on this company. It was laughable and I believe those not in the deal loop have reacted in anger instead of objective ratings like they should have. Holders of this stock stand to be well rewarded as it isn't well followed yet holds a power punch of potential.

    Could be Mylan, Pfizer or even GSK due to the prorietary developments unfolding. I think a mid $40 offer fair value when you add up the parts and potential of the Rytary approval that is forthcoming. Next few weeks should be exciting for the company. Obviously something big is in the works evidenced by the spat of ratings and price upgrades.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
IPXL
31.54+0.22(+0.70%)Dec 22 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Gilead Sciences Inc.
NASDAQMon, Dec 22, 2014 4:00 PM EST
AbbVie Inc.
NYSEMon, Dec 22, 2014 4:05 PM EST